Acoustic Neurinoma Treatment Market Trends and Competitive Landscape Acoustic Neurinoma Healthcare | Page 4

Acoustic Neurinoma Treatment Market Globally Expected to Drive Growth
through 2027
Acoustic Neurinoma is a noncancerous growth that develops on the cranial nerve. Acoustic Neurinoma
also known as develops on the vestibulocochlear nerve or the eight cranial nerve which connects the
inner ear with the brain. The vestibulocochlear nerve has two parts, one helps in sending balance
information and other involved in transmitting sound from ear to the brain. Acoustic Neurinoma also
known by the name neurolemmomas or vestibular schwannomas. Although acoustic neurinoma do not
invade the brain, they may push on it as they grow. But they may be deadly, if they become large enough
to press on the cerebellum or stem.
Acoustic Neurinoma Treatment Market: Drivers and Restraints
Acoustic neurinoma is expected to witness growth with the increasing number of government funding
and also the introduction of new technologies. The UK government announced US$ 5.58 million funding
to study the risk of brain tumor in relation to use of mobiles. As acoustic neurinoma is a rare disease, it
has few market players, market expansion is the strategy used by the market players. For instance,
Accuray Inc. signed an agreement with Christie InnoMed Inc. to market its CyberKnife and TomoTherapy
System product portfolios in Canada.
Acoustic Neurinoma Treatment Market: Segmentation
Acoustic neurinoma treatment market is classified on the basis of treatment, end-users and region.
©2015 Future Market Insights, All Rights Reserved
4